Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Takeda Pharmaceutical
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : As part of the agreement, ProThera and Takeda will work together on IND-enabling activities, with development led by Takeda's dedicated Plasma Derived Therapies R&D organization.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 23, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Takeda Pharmaceutical
Deal Size : Undisclosed
Deal Type : Licensing Agreement